5,7-Dichloro-1,8-naphthyridin-2-amine, 95.0%, 250mg

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 10mg

(2-((3R,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)cyclohexylidene)ethyl)diphenylphosphine oxide, 98%, 100mg

(R)-1-(5-Bromothiophen-2-yl)ethan-1-amine hydrochloride, 95%, 100mg

(1S)-6-BROMO-5-CHLOROINDANYLAMINE, 95.0%, 250mg

Potassium 3-pyrazin-2-yl-1,2,4-oxadiazole-5-carboxylate, 95.0%, 1g

4-Chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, 98%, 1g

tert-Butyl 2-oxo-1,7-diazaspiro[4.4]nonane-7-carboxylate, 95.0%, 1g

(3-Bromo-5-fluoropyridin-2-yl)methanol, 95+%, 500mg

Dihydro-1-(2-methoxyethyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione, 97%, 100mg

3-Bromo-6-methoxypicolinonitrile, 95.0%, 25g

Tapones ROTILABO®, 14 mm, 25 Pieza(s)

D-1-Boc-1,2,3,4-Tetrahydro-quinoline-2-carboxylic acid, 97.0%, 5g